A prospective post-marketing observational study of abemaciclib in patients with HR+, HER2- breast cancer in China
在中国开展的阿贝西利治疗HR+、HER2-乳腺癌患者的上市后前瞻性观察研究
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag013
Ouyang, Quchang; Yuan, Peng; Liu, Jianxia; Teng, Yuee; Li, Zhihua; Ji, Xuening; Liu, Lina; Wang, Mopei; Zou, Liqun; Xu, Ling; Yang, Suisheng; Zhu, Zhenxin; Yang, Liu; Li, Jinnan; Liu, Qiang